Pyrimidinone compounds as human neutrophil elastase inhibitors

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9828382
APP PUB NO 20160251362A1
SERIAL NO

15150749

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Pyrimidone compounds defined herein exhibit human neutrophil elastase inhibitory properties and are useful for treating diseases and condition in which HNE is implicated.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
CHIESI FARMACEUTICI S P AVIA PALERMO 26/A PARMA 43122

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Alcaraz, Lilian Harlow, GB 36 219
Armani, Elisabetta Parma, IT 69 430
Capaldi, Carmelida Parma, IT 32 122
Heald, Robert Andrew Harlow, GB 29 148
Sutton, Jonathan Mark Harlow, GB 37 203

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 May 28, 2025
11.5 Year Payment $7400.00 $3700.00 $1850.00 May 28, 2029
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00